SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (662)5/10/2004 2:57:14 PM
From: tuck  Read Replies (2) of 897
 
They'll probably try to make something of their results to date at ASCO. Assuming some kind of market bounce before then, we should get a good entry before what looks like a more typical summer. I was tempted to hit it at $60, and am sorry I didn't. I simply expected a bounce before now, and an even higher entry price.

Wondering if we're near bottom here before ASCO. As such, looking to take profits in any oncology stock shorts. Starting with AGEN, which has taken over a year to return 3 or 4 per cent. Out at $8.80 with a profit of $624, on 20K invested. May re-enter around ASCO.

Watching OXGN. If I'm wrong about this being a short term bottom, I'll hope we're at least close, and take profits in that one shortly. If I'm right, I'll wait till summer. Currently around breakeven on that one.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext